Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,411,232,013
+$727,043,035 QoQ
Shares Held
28,537,243
+20.2% QoQ
Ownership
1.84%
of shares outstanding
% of Portfolio
0.94%
of 13F equity value
Holder Rank
#7
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 94%
None 6%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $41,461,553,100 across 12 Drug Manufacturers - General names. AZN ranks #4 (13.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,998,953 | $13,192,475,293 | |
| 2 | MRK |
Merck & Co., Inc.
|
86,249,283 | $11,083,032,864 | |
| 3 | JNJ |
Johnson & Johnson
|
22,588,696 | $5,736,851,118 | |
| 4 | AZN |
Astrazeneca PLC
This page
|
28,537,243 | $5,411,232,013 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
12,699,683 | $1,604,477,945 | |
| 6 | ABBV |
AbbVie Inc.
|
5,055,589 | $1,272,188,413 | |
| 7 | AMGN |
Amgen Inc
|
2,742,271 | $993,031,171 | |
| 8 | BIIB |
Biogen Inc.
|
3,117,469 | $673,560,350 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,411,232,013 | 28,537,243 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,684,188,978 | 23,751,085 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||